0000950170-24-014128.txt : 20240212 0000950170-24-014128.hdr.sgml : 20240212 20240212212403 ACCESSION NUMBER: 0000950170-24-014128 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Couling John D CENTRAL INDEX KEY: 0001894052 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 24622315 MAIL ADDRESS: STREET 1: C/O DOLBY LABORATORIES, INC. STREET 2: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0927 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4/A 1 ownership.xml 4/A X0508 4/A 2024-02-08 2024-02-12 0001308547 Dolby Laboratories, Inc. DLB 0001894052 Couling John D C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 false true false false SVP, Entertainment true Class A Common Stock 2024-02-08 4 M false 50000 42.98 A 158519 D Class A Common Stock 2024-02-08 4 S false 50000 80 D 108519 D Class A Common Stock 2024-02-09 4 M false 12440 42.98 A 120959 D Class A Common Stock 2024-02-09 4 M false 21120 62.32 A 142079 D Class A Common Stock 2024-02-09 4 S false 33560 80.8074 D 108519 D Employee Stock Option (Right to Buy) 42.98 2024-02-08 4 M false 50000 0 D 2024-12-15 Class A Common Stock 50000 12440 D Employee Stock Option (Right to Buy) 42.98 2024-02-09 4 M false 12440 0 D 2024-12-15 Class A Common Stock 12440 0 D Employee Stock Option (Right to Buy) 62.32 2024-02-09 4 M false 21120 0 D 2024-12-15 Class A Common Stock 21120 0 D The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares. /s/ Daniel Rodriguez as Attorney-in-Fact for John Couling 2024-02-12